Loading…
Reported covered position: Deputy Assistant to the President for Leg Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2026 · third_quarter · Q3
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD
Source: Senate LDA
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
National Defense Authorization Act for Fiscal Year 2027
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
American Relief Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
American Relief Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
American Relief Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
American Relief Act, 2025
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
School Access to Naloxone Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Language Access for Medicare Beneficiaries Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Language Access for Medicare Beneficiaries Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Language Access for Medicare Beneficiaries Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Language Access for Medicare Beneficiaries Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Saving Lives in Schools Act of 2023
Client: EMERGENT BIOSOLUTIONS INC · Firm: EMERGENT BIOSOLUTIONS INC.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2026 · second_quarter · Q2
Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2026 · first_quarter · Q1
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2025 · fourth_quarter · Q4
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield forFY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2025 · third_quarter · Q3
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025 - H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025 - H.R.5252, Having Overdoes Protection Equipment Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2025 · second_quarter · Q2
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2025 · first_quarter · Q1
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2024 · fourth_quarter · Q4
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2024 · third_quarter · Q3
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2024 · second_quarter · Q2
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2024 · first_quarter · Q1
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2023 · fourth_quarter · Q4
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2023 · third_quarter · Q3
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act (P.L.116-22). Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 (H.R.2670) - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act (P.L.116-22). Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 (H.R.2670) - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2023 · second_quarter · Q2
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2023 · first_quarter · Q1
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2022 · fourth_quarter · Q4
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2022 · third_quarter · Q3
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines H.R.3263 Outreach - DHS Medical Countermeasures Act
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2022 · second_quarter · Q2
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2022 · first_quarter · Q1
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2021 · fourth_quarter · Q4
Appropriations funding for Fiscal Year 2022, H.R.6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Appropriations funding for Fiscal Year 2022, H.R.6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2021 · third_quarter · Q3
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2021 · second_quarter · Q2
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2021 · first_quarter · Q1
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2020 · fourth_quarter · Q4
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2020 · third_quarter · Q3
H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act, FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. The National Defense Authorization Act (NDAA) - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, Plasma Donation Awareness Act of 2020, and S. 4179, Plasma Donation Awareness Act that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act. H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce). H.R. 8406 - The Heroes Act. S.4231 - Preparing for the Next Pandemic Act. HEALS Act.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2020 · second_quarter · Q2
-Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act-H.R. 6800), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -State Opioid Response Grants funding for FY 2021 -NDAA - provisions related to biological and chemical defense -Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder (H.R. 6620) -Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.
-Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act-H.R. 6800), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -State Opioid Response Grants funding for FY 2021 -NDAA - provisions related to biological and chemical defense -Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder (H.R. 6620) -Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2020 · first_quarter · Q1
-H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations -Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
-H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations -Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of the Vice President of the United States, SENATE, White House Office
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2019 · fourth_quarter · Q4
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures -FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures -FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2019 · third_quarter · Q3
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -Re-authorization of the Pandemic and All-Hazards Preparedness Act -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures -FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2019 · second_quarter · Q2
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2019 · first_quarter · Q1
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2018 · fourth_quarter · Q4
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines FY19 Appropriations - Provisions related to Naloxone funding, Naloxone access and oversight State Targeted Response/State Opioid Response Grants
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines FY19 Appropriations - Provisions related to Naloxone funding, Naloxone access and oversight State Targeted Response/State Opioid Response Grants
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2018 · third_quarter · Q3
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2018 · second_quarter · Q2
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2018 · first_quarter · Q1
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2017 · fourth_quarter · 4A
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2017 · fourth_quarter · Q4
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2017 · third_quarter · Q3
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2017 · second_quarter · Q2
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling medical countermeasures Provisions related to development, acquisition and stockpiling medical countermeasures
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling medical countermeasures Provisions related to development, acquisition and stockpiling medical countermeasures
FY 2018 Appropriations - provisions related to development, acquisition and stockpiling medical countermeasures Provisions related to development, acquisition and stockpiling medical countermeasures
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2017 · first_quarter · Q1
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2016 · fourth_quarter · Q4
Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination
Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015 H.R. 34 - 21st Century Cures
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2016 · third_quarter · Q3
Department of Labor, Health and Human Services,Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination
Department of Labor, Health and Human Services,Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2016 · second_quarter · Q2
H.R.4400 and S 2512 - Adding Zika Virus to the FDA Priority Review Program Act - entire bill
Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination
Draft-Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2016 · first_quarter · Q1
Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination.
Draft-Department of Labor, Health and Human Services, Education and Related Agencies - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination. H.R. 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2015 · fourth_quarter · Q4
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies' 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R. 1300 and S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack. H.R. 3299 - Strengthening Public Health Emergency Response Act of 2016 - entire bill reforming federal preparedness for biothreats.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2015 · third_quarter · Q3
H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies,2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R. 1300 and S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2015 · second_quarter · Q2
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 2685 and S 1558 Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. HR 1735 and S118 National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 2685 and S 1558 Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness HR 1735 and S118 National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2015 · first_quarter · Q1
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. Draft - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness Draft - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2014 · fourth_quarter · Q4
HR 83 Consolidated and Further Continuing Appropriations Act, 2015 - Department of Labor, Health and Human Services, Education and related Agencies', Department of Defense and Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquistion and stockpiling of biodefense vaccines.
HR 83 Consolidated and Further Continuing Appropriations Act, 2015 - Department of Labor, Health and Human Services, Education and related Agencies', Department of Defense and Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquistion and stockpiling of biodefense vaccines. HR 5620 First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. HR 3979 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination. HR 4007 Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2014 · third_quarter · Q3
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.Draft - Departments of LHHS Appropriation bill, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 4435 and S 2410 - National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act. HJ Res 124 - Continuing Appropriations Resolution, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 5620 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency responders.
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.Draft - Departments of LHHS Appropriation bill, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HJ Res 124 - Continuing Appropriations Resolution, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2014 · second_quarter · Q2
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft - Department of LHHS, Education and Related Agencies Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 4435 - National Defense Authorization Act for Fiscal Year 2015 - provisions related to chemical decontamination; S 2410 - National Defense Authorization Act for Fiscal Year 2015 - provisions related to chemical decontamination HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to chemical decontamination HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft - Department of LHHS, Education and Related Agencies Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 4435 - National Defense Authorization Act for Fiscal Year 2015 - provisions related to chemical decontamination; S 2410 - National Defense Authorization Act for Fiscal Year 2015 - provisions related to chemical decontamination HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to chemical decontamination HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2014 · first_quarter · Q1
HR 4007 Chemical Facility Anti-Terrorism Standards Program Authorization and Accountability Act of 2014. HR 4034 - WMD Prevention and Preparedness Act of 2014 - to enhance homeland security by improving efforts to prevent, protect agaisnt, respond to, and recover from an attack with a weapon of mass destruction, and for other purposes. HR 3547 Consolidated Appropriations Act, 2014, DHS 2014 and LHHS 2014 - provisions related to development, acquistion and stockpiling of biodefense vaccines.Draft Consolidated Appropriations Act 2015, DHS Appropriations Act and LHHS Appropriations Act - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Draft National Defense Authorization Act for Fiscal Year 2015 - provisions relatd to chemical decontamination
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2013 · fourth_quarter · Q4
HR 3304, National Defense Authorization Act for Fiscal Year 2013, issues relating to chemical decontimination.
HR 2217, Dept of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; SB 1284, Dept Labor HHS, provisions related to development, acquisition and stockpiling of biodefense vaccines;HJ Res 59 - Continuing Appropriations Resolution - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 2217, Dept of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; SB 1284, Dept Labor HHS, provisions related to development, acquisition and stockpiling of biodefense vaccines;HJ Res 59 - Continuing Appropriations Resolution - provisions related to development, acquisition and stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2013 · third_quarter · Q3
HR 2217, Department of Homeland Security Appropriations Act, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines; Draft Fiscal Year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations bill, provisions related to the development, acquisition and stockpiling of biodefense vaccines;HJ Res. 59 - Continuing Appropriations Resolution, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines.
HR 2217, Department of Homeland Security Appropriations Act, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines; Draft Fiscal Year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations bill, provisions related to the development, acquisition and stockpiling of biodefense vaccines;HJ Res. 59 - Continuing Appropriations Resolution, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2013 · second_quarter · Q2
HR 2217 and draft Senate bill - Department of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 2217 and draft Senate bill - Department of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2013 · first_quarter · Q1
H.R.307 and S. 242 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - entire bill reauthorizing funding and strengthening bioterorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs);H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 - Division D - Department of Homeland Security Appropriations, 2013, and Titles I and V of Division F - Labor, Health and Human Services, and Education, and Related Agencies Appropriations - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Department of Homeland Security appropriations bill - same issues as previously stated; Draft fiscal year 2014 Departments of Health and Human Services and Education, and related agencies appropriations bill - same issues as previously stated.
H.R.307 and S. 242 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - entire bill reauthorizing funding and strengthening bioterorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs);H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 - Division D - Department of Homeland Security Appropriations, 2013, and Titles I and V of Division F - Labor, Health and Human Services, and Education, and Related Agencies Appropriations - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Department of Homeland Security appropriations bill - same issues as previously stated; Draft fiscal year 2014 Departments of Health and Human Services and Education, and related agencies appropriations bill - same issues as previously stated.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2012 · fourth_quarter · Q4
HR 5855 and S. 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S. 3295 & House draft bill - Departments of Labor, Health & Human Services & Education Appropriations Act, 2013 - same as above; HR 2356 - WMD Prevention and Preparedness Act of 2012 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S.1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BioMedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs).
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S. 3295 & House draft bill - Departments of Labor, Health & Human Services & Education Appropriations Act, 2013 - same as above; HR 2356 - WMD Prevention and Preparedness Act of 2012 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S.1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BioMedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs).
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2012 · third_quarter · Q3
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S 3295 and House draft bill - Departments of Labor, Health and Human Services & Education Appropriations Act, 2013 - same as above. HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquistions and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - reauthorizing funding and strengthening bioterrorism preparedness programs, including Biomedical Advance Research & Development Authority (BARDA) and the development of medical countermeasure (MCMs).
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S 3295 and House draft bill - Departments of Labor, Health and Human Services & Education Appropriations Act, 2013 - same as above. HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquistions and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - reauthorizing funding and strengthening bioterrorism preparedness programs, including Biomedical Advance Research & Development Authority (BARDA) and the development of medical countermeasure (MCMs).
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2012 · second_quarter · Q2
HR 5855 and S 3216 - Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations Act for Fiscal Year 2013 S 3295 - provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BARDA and the development of MCMs.
HR 5855 and S 3216 - Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations Act for Fiscal Year 2013 S 3295 - provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BARDA and the development of MCMs.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2012 · first_quarter · Q1
Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act -- provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act -- provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2011 · fourth_quarter · Q4
H.R. 2055 - Consolidated Appropriations Act, 2012, Division D, Department of Homeland Security Appropriations Act and Division F, Departments of Labor, Health and Human Services and Education Appropriations Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
H.R. 2055 - Consolidated Appropriations Act, 2012, Division D, Department of Homeland Security Appropriations Act and Division F, Departments of Labor, Health and Human Services and Education Appropriations Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2011 · third_quarter · Q3
Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2011 · second_quarter · Q2
Fiscal 2012 - Departments of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2017 - Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Prepardeness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Fiscal 2012 - Departments of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2017 - Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Prepardeness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2011 · first_quarter · Q1
H.R. 1 Full Year Appropriations Act, 2011, and Senate Amendment 149 - all provisions and funding related to development, acquisition and stockpiling of biodefense vaccines in the Department of Health and Human Services and Homeland Security; Fiscal 2011 Continuing Resolution - same as above; Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Department of Homeland Security appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Proposals for WMD Prevention and Preparedness - provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
H.R. 1 Full Year Appropriations Act, 2011, and Senate Amendment 149 - all provisions and funding related to development, acquisition and stockpiling of biodefense vaccines in the Department of Health and Human Services and Homeland Security; Fiscal 2011 Continuing Resolution - same as above; Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Department of Homeland Security appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Proposals for WMD Prevention and Preparedness - provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2010 · fourth_quarter · Q4
S.3686 - Department of Labor, Health & Human Services and Education Appropriations Act 2011 - all provisions relating to development, acquistion and stockpiling of biodefense vaccines; S. 3607 - Department of Homeland Security Appropriations Act 2011 - all provisions relating to developement, acquistion and stockpiling of biodefense vaccines; S.1649 and H.R.5498 - WMD Prevention and Preparedness Act of 2009 - all provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2010 · third_quarter · Q3
S.3686 - Departments of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; S.3607 - Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisitions and stockpiling of biodefense vaccines; S.1649 and H.R. 5498 WMD Prevention and Preparedness Act of 2009 - all provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2010 · second_quarter · Q2
P.L. 115-5 - American Recovery Act of 2009 -implementation of provisions relating to biodefense funding; Department of Labor, Health & Human Services and Education Appropriations Act of 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2011 - all provisions relating to the development, acquisition and stockpiling of biodefense vaccines; S. 1649 and H.R. 5498 - WMD Prevention and Preparedness Act of 2009 - all provisions relating to the acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2010 · first_quarter · Q1
P.L. 115-5 - American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding; Department of Labor, Health & Human Services and Education Appropriations Act for 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Department of Homeland Security Appropriations Act, 2011 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; S. 1649 - WMD Prevention of Prepardeness Act of 2009 - all provisions relating to acquistion and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2009 · fourth_quarter · Q4
P.L. 115-5 - American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding; H.R.3288 - Consolidated Appropriations Act, 2010, Division D - Department of Labor, Health & Human Services and Education Appropriations Act of 2010 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines. H.R. 2892 and S. 1298 - Department of Homeland Security Appropriations Act, 2010 - all provisions relating to the development, acquistion and stockpiling of biodefense vaccines; S. 1649 - WMD Prevention and Prepardeness Act of 2009 - all provisions relating to the development , acquistion and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relationg to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2009 · third_quarter · Q3
P.L. 115-5 - American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding; H.R.3288 - Consolidated Appropriations Act, 2010, Division D - Department of Labor, Health & Human Services and Education Appropriations Act of 2010 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines. H.R. 2892 and S. 1298 - Department of Homeland Security Appropriations Act, 2010 - all provisions relating to the development, acquistion and stockpiling of biodefense vaccines; S. 1649 - WMD Prevention and Prepardeness Act of 2009 - all provisions relating to the development , acquistion and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relationg to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2009 · third_quarter · Q3
P.L. 115-5 - American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding; H.R. 3293 - Department of Labor, Health & Human Services and Education Appropriations Act for 2010 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines. H.R. 2892 - Department of Homeland Security Appropriations Act 2010 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines. S1649 - WMD Prevention and Preparedness Act of 2009 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines. Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project Bioshield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2009 · second_quarter · Q2
P.L. 115-5-American Recovery & Reinvestment Act of 2009 - implementation of provisions relating to biodefense funding; Departments of Labor, Health & Human Services and Education Appropriations for 2010 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
EMERGENT BIOSOLUTIONS INC via EMERGENT BIOSOLUTIONS INC.
2009 · first_quarter · Q1
H.R. 1105 Omnibus Appropriations Act 2009, Departments of Labor, Health and Human Services and Education 2009- all provisions relating to the development, acquisition and stockpiling of biodefense vaccines; H.R. 1 and S.1 American Recovery & Reinvestment Act of 2009 - provisions relating to biodefense funding
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
- Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY25 and FY26 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 - Tribal Opioid Response Grant funding for FY26 - NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone - H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 and FY26 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY25 and FY26 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY25 and FY26 NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act (P.L.116-22). Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 (H.R.2670) - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act (P.L.116-22). Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 (H.R.2670) - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24. NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding Substance Abuse and Mental Health Block Grant (SABG) funding National Defense Authorization Act for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act H.R.3263 Outreach - DHS Medical Countermeasures Act
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.2617 - Consolidated Appropriations Act, 2023 (Omnibus) H.R.1437 - Further Continuing Appropriations and Extensions Act State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341/S.987 - CARA 3.0 Act of 2021 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366/S.1457 - STOP Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - Provisions related to biological and chemical defense and access to Naloxone House and Senate appropriations for FY 2023 State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341/S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366/S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 H.R.7681 - Preventing Overdoses and Saving Lives Act 2.0 H.R.7666 - the Restoring Hope for Mental Health and Well-Being Act of 2022 S.3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, H.R. 6119 - Further Extending Government Funding Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone. State Opioid Response (SOR) Grants funding. H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding. H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Appropriations funding for Fiscal Year 2022, H.R.6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act H.R.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Appropriations funding for Fiscal Year 2022, H.R.6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone State Opioid Response (SOR) Grants funding H.R.2379 - The State Opioid Response Grant Authorization Act of 2021 Substance Abuse and Mental Health Block Grant (SABG) funding H.R.4341; S.987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2366; S.1457 - Stop Fentanyl Act HR.5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R.3263 Outreach - DHS Medical Countermeasures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R. 2366 S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act, FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. The National Defense Authorization Act (NDAA) - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, Plasma Donation Awareness Act of 2020, and S. 4179, Plasma Donation Awareness Act that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act. H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce). H.R. 8406 - The Heroes Act. S.4231 - Preparing for the Next Pandemic Act. HEALS Act.
H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act, FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. The National Defense Authorization Act (NDAA) - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, Plasma Donation Awareness Act of 2020, and S. 4179, Plasma Donation Awareness Act that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act. H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce). H.R. 8406 - The Heroes Act. S.4231 - Preparing for the Next Pandemic Act. HEALS Act.
H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act, FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. The National Defense Authorization Act (NDAA) - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, Plasma Donation Awareness Act of 2020, and S. 4179, Plasma Donation Awareness Act that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act. H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce). H.R. 8406 - The Heroes Act. S.4231 - Preparing for the Next Pandemic Act. HEALS Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
-Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act-H.R. 6800), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -State Opioid Response Grants funding for FY 2021 -NDAA - provisions related to biological and chemical defense -Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder (H.R. 6620) -Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
-FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government -NDAA - provisions related to biological and chemical defense -Department of Defense appropriations for Medical Countermeasures -FDA regulatory issues -Issues related to Priority Review Voucher programs -Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 FDA regulatory issues Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines FY19 Appropriations - Provisions related to Naloxone funding, Naloxone access and oversight State Targeted Response/State Opioid Response Grants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Department of Labor, Health and Human Services,Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015 H.R. 34 - 21st Century Cures
Department of Labor, Health and Human Services,Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination
Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2017- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness National Defense Authorization Act for Fiscal Year 2017 - issues related to the National Biodefense Plan and chemical decontamination H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Draft-Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination H.R. 1300 - - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
Draft-Department of Labor, Health and Human Services , Education and Related Agencies- provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Draft-Department of Labor, Health and Human Services, Education and Related Agencies - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination. H.R. 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
Draft-Department of Labor, Health and Human Services, Education and Related Agencies and Draft -Department of Homeland Security Appropriations Act, 2017 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2017 - provisions related to chemical decontamination and Ebola response preparedness Draft- National Defense Authorization Act for Fiscal Year 2017 - issues related to chemical decontamination. H.R. 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R. 3299 - The Strengthening Public Health Emergency Response Act of 2015 S 2055 - Medical Countermeasure Innovation Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R. 1300 and S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack. H.R. 3299 - Strengthening Public Health Emergency Response Act of 2016 - entire bill reforming federal preparedness for biothreats.
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies' 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 1300 and S. 1915 - First Responder Anthrax Preparedness Act - entire bill relating to anthrax vaccines for emergency response providers.
H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
H.R. 3020 and S 1695- Department of Labor, Health and Human Services , Education and Related Agencies', 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 3128 and S 1619 - Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 2685 and S. 1558- Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness H.R. 1300 and S 1915 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. H.R 1735 & S.1118 - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2685 and S 1558 Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness HR 1735 and S118 National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 2685 and S 1558 Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. HR 1735 and S118 National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Draft - Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness Draft - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination
Draft - Department of Labor, Health and Human Services , Education and Related Agencies and Department of Homeland Security Appropriations Act, 2016 - provisions related to development, acquisition and stockpiling of biodefense vaccines. Draft - Department of Defense Appropriations 2016 - provisions related to chemical decontamination and Ebola response preparedness HR 1300 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. Draft - National Defense Authorization Act for Fiscal Year 2016 - issues related to chemical decontamination H.R. 361 - Medical Preparedness Allowable Use Act - stockpiling of medical countermeasures for a chemical or biological attack.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 83 Consolidated and Further Continuing Appropriations Act, 2015 - Department of Defense - provisions related to development, acquistion and stockpiling of biodefense vaccines. HR 3979 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination.
HR 83 Consolidated and Further Continuing Appropriations Act, 2015 - Department of Labor, Health and Human Services, Education and related Agencies', Department of Defense and Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquistion and stockpiling of biodefense vaccines. HR 5620 First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency response providers. HR 3979 National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination. HR 4007 Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 4435 and S 2410 - National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.Draft - Departments of LHHS Appropriation bill, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 4435 and S 2410 - National Defense Authorization Act for Fiscal 2015 - issues related to chemical decontamination HR 4007 - Chemical Facility Anti-Terrorism Standard Program Authorization and Accountability Act. HJ Res 124 - Continuing Appropriations Resolution, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines. HR 5620 - First Responder Anthrax Preparedness Act - directs the Secretary of Homeland Security to make anthrax vaccines and antimicrobials available to emergency responders.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4435 - National Defense Authorization Act for Fiscal Year 2015 - provisions related to chemical decontamination; S 2410 - National Defense Authorization Act for Fiscal Year 2015 - provisions related to chemical decontamination HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to chemical decontamination
HR 4903 and S 2534 - Department of Homeland Security Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft - Department of LHHS, Education and Related Agencies Appropriations Act, 2015 - provisions related to development, acquisition and stockpiling of biodefense vaccines.HR 4870 and Draft Senate bill - Department of Defense Appropriations Act, 2015 - provisions related to chemical decontamination.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 4007 Chemical Facility Anti-Terrorism Standards Program Authorization and Accountability Act of 2014. HR 4034 - WMD Prevention and Preparedness Act of 2014 - to enhance homeland security by improving efforts to prevent, protect agaisnt, respond to, and recover from an attack with a weapon of mass destruction, and for other purposes. HR 3547 Consolidated Appropriations Act, 2014, DHS 2014 and LHHS 2014 - provisions related to development, acquistion and stockpiling of biodefense vaccines.Draft Consolidated Appropriations Act 2015, DHS Appropriations Act and LHHS Appropriations Act - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4007 Chemical Facility Anti-Terrorism Standards Program Authorization and Accountability Act of 2014. HR 4034 - WMD Prevention and Preparedness Act of 2014 - to enhance homeland security by improving efforts to prevent, protect agaisnt, respond to, and recover from an attack with a weapon of mass destruction, and for other purposes. HR 3547 Consolidated Appropriations Act, 2014, DHS 2014 and LHHS 2014 - provisions related to development, acquistion and stockpiling of biodefense vaccines.Draft Consolidated Appropriations Act 2015, DHS Appropriations Act and LHHS Appropriations Act - provisions related to development, acquisition and stockpiling of biodefense vaccines.
HR 4007 Chemical Facility Anti-Terrorism Standards Program Authorization and Accountability Act of 2014. HR 4034 - WMD Prevention and Preparedness Act of 2014 - to enhance homeland security by improving efforts to prevent, protect agaisnt, respond to, and recover from an attack with a weapon of mass destruction, and for other purposes. HR 3547 Consolidated Appropriations Act, 2014, DHS 2014 and LHHS 2014 - provisions related to development, acquistion and stockpiling of biodefense vaccines.Draft Consolidated Appropriations Act 2015, DHS Appropriations Act and LHHS Appropriations Act - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2217, Dept of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; SB 1284, Dept Labor HHS, provisions related to development, acquisition and stockpiling of biodefense vaccines;HJ Res 59 - Continuing Appropriations Resolution - provisions related to development, acquisition and stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2217, Department of Homeland Security Appropriations Act, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines; Draft Fiscal Year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations bill, provisions related to the development, acquisition and stockpiling of biodefense vaccines;HJ Res. 59 - Continuing Appropriations Resolution, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines.
HR 2217, Department of Homeland Security Appropriations Act, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines; Draft Fiscal Year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations bill, provisions related to the development, acquisition and stockpiling of biodefense vaccines;HJ Res. 59 - Continuing Appropriations Resolution, 2014 - provisions related to the development, acquisition and stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2217 and draft Senate bill - Department of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines
HR 2217 and draft Senate bill - Department of Homeland Security Appropriations Act, 2014 - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Departments of Labor, Health and Human Services, Education and Related Agencies appropriations bill - provisions related to development, acquisition and stockpiling of biodefense vaccines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.307 and S. 242 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - entire bill reauthorizing funding and strengthening bioterorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs);H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 - Division D - Department of Homeland Security Appropriations, 2013, and Titles I and V of Division F - Labor, Health and Human Services, and Education, and Related Agencies Appropriations - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Department of Homeland Security appropriations bill - same issues as previously stated; Draft fiscal year 2014 Departments of Health and Human Services and Education, and related agencies appropriations bill - same issues as previously stated.
H.R.307 and S. 242 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 - entire bill reauthorizing funding and strengthening bioterorism preparedness programs, including Biomedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs);H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 - Division D - Department of Homeland Security Appropriations, 2013, and Titles I and V of Division F - Labor, Health and Human Services, and Education, and Related Agencies Appropriations - provisions related to development, acquisition and stockpiling of biodefense vaccines; Draft fiscal year 2014 Department of Homeland Security appropriations bill - same issues as previously stated; Draft fiscal year 2014 Departments of Health and Human Services and Education, and related agencies appropriations bill - same issues as previously stated.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S. 3295 & House draft bill - Departments of Labor, Health & Human Services & Education Appropriations Act, 2013 - same as above; HR 2356 - WMD Prevention and Preparedness Act of 2012 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S.1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BioMedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs).
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S. 3295 & House draft bill - Departments of Labor, Health & Human Services & Education Appropriations Act, 2013 - same as above; HR 2356 - WMD Prevention and Preparedness Act of 2012 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S.1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BioMedical Advanced Research & Development Authority (BARDA) and the development of medical countermeasures (MCMs).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S 3295 and House draft bill - Departments of Labor, Health and Human Services & Education Appropriations Act, 2013 - same as above. HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquistions and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - reauthorizing funding and strengthening bioterrorism preparedness programs, including Biomedical Advance Research & Development Authority (BARDA) and the development of medical countermeasure (MCMs).
HR 5855 and S 3216 - Department of Homeland Security Appropriations, 2013 - provisions relating to development, acquistion and stockpiling of biodefense vaccines; S 3295 and House draft bill - Departments of Labor, Health and Human Services & Education Appropriations Act, 2013 - same as above. HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquistions and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - reauthorizing funding and strengthening bioterrorism preparedness programs, including Biomedical Advance Research & Development Authority (BARDA) and the development of medical countermeasure (MCMs).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5855 and S 3216 - Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations Act for Fiscal Year 2013 S 3295 - provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BARDA and the development of MCMs.
HR 5855 and S 3216 - Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations Act for Fiscal Year 2013 S 3295 - provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; HR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BARDA and the development of MCMs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act -- provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations for Fiscal Year 2013 Act -- provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 and S. 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2055 - Consolidated Appropriations Act, 2012, Division D, Department of Homeland Security Appropriations Act and Division F, Departments of Labor, Health and Human Services and Education Appropriations Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
H.R. 2055 - Consolidated Appropriations Act, 2012, Division D, Department of Homeland Security Appropriations Act and Division F, Departments of Labor, Health and Human Services and Education Appropriations Act - provisions relating to development , acquisition and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Fiscal 2012 - Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; H.R. 2017 & H.R. 2608 - Continuing Appropriations Act, 2012 - provisions relating to the Department of Homeland Security Appropriations Act, 2012, and the development, acquistion and stockpiling of biodefense vaccines; H.R. 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; H.R. 2405 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs; Implementation and re-authorization of the BioMedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Fiscal 2012 - Departments of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2017 - Department of Homeland Security Appropriations Act, 2012 - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Prepardeness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation and re-authorization of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1 Full Year Appropriations Act, 2011, and Senate Amendment 149 - all provisions and funding related to development, acquisition and stockpiling of biodefense vaccines in the Department of Health and Human Services and Homeland Security; Fiscal 2011 Continuing Resolution - same as above; Department of Labor, Health and Human Services and Education appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Department of Homeland Security appropriations - all provisions relating to development, acquisition and stockpiling of biodefense vaccines; Proposals for WMD Prevention and Preparedness - provisions relating to acquisition and stockpiling of biodefense vaccines; Implementation of the Biomedical Advanced Research & Development Authority (BARDA) & Project BioShield relating to stockpiling of biodefense vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE